MedTrace Logo

Integrative Analysis of CRC Liver Metastasis

NCT02917707 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2016-09-28

No results posted yet for this study

Summary

The investigators will perform integrative analysis of CRC liver metastasis

Conditions

  • Metastasis

Interventions

OTHER

normal colorectal tissues

The investigators will extract total protein, DNA and RNA from these groups.

Sponsors & Collaborators

  • Ganzhou City People's Hospital

    collaborator OTHER

  • Da Fu

    lead OTHER

Principal Investigators

  • Da Fu, Ph.D. · the Shanghai Tenth People's Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02917707 on ClinicalTrials.gov